tiprankstipranks
Trending News
More News >

David Krempa Insider Profile

4 Followers
David Krempa, CBO at Eton Pharmaceuticals, holds 632.18K shares in Eton Pharmaceuticals (Ticker: ETON).
tipranks
David Krempa

David Krempa
Eton Pharmaceuticals (ETON)
CBO

Not Ranked
David Krempa has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
100.00%
A breakdown of David Krempa's holdings

Insider Roles

Eton Pharmaceuticals
(ETON)
CBO
Roles that David Krempa holds in companies

Most Profitable Insider Trade

Stock:
Eton Pharmaceuticals
(ETON)
Rating:Informative Sell
Date:Jun 16, 2025 - Today
Return:-15.50%
The most profitable trade made by David Krempa

David Krempa's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eton Pharmaceuticals
Dec 12, 2025
CBO
Uninformative Sell
106.49K
$10.46M
Success Rate for
ETON
0 out of 1 profitable transactions on
ETON
0%
Average Return for
ETON
Average return per transaction on
ETON
-15.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jun 16, 2025
Informative Sell
$504.32K
-
$14.83
-15.50%
Dec 12, 2025
Uninformative Sell
$106.49K
-
$17.00
List of latest transactions for each holding click on a transaction to see David Krempa's performance on stock

David Krempa insider profile FAQ

What is the percentage of profitable transactions made by David Krempa?
The percentage of profitable transactions made by David Krempa is ―.
    What is the average return per transaction made by David Krempa?
    The average return per transaction made by David Krempa is ―.
      What stocks does David Krempa hold?
      David Krempa holds: ETON stocks.
        What was David Krempa’s latest transaction?
        David Krempa latest transaction was an Uninformative Sell of $106.49K.
          What was David Krempa's most profitable transaction?
          David Krempa’s most profitable transaction was an Informative Sell of ETON stock on June 16, 2025. The return on the trade was -15.50%.
            What is David Krempa's role in Eton Pharmaceuticals?
            David Krempa's role in Eton Pharmaceuticals is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.